APA (7th ed.) Citation

Alvi, M. A., Loughrey, M. B., Dunne, P., McQuaid, S., Turkington, R., Fuchs, M., . . . Salto-Tellez, M. (2017). Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. British journal of cancer, 117(2), 203-209. https://doi.org/10.1038/bjc.2017.168

Chicago Style (17th ed.) Citation

Alvi, Muhammad A., et al. "Molecular Profiling of Signet Ring Cell Colorectal Cancer Provides a Strong Rationale for Genomic Targeted and Immune Checkpoint Inhibitor Therapies." British Journal of Cancer 117, no. 2 (2017): 203-209. https://doi.org/10.1038/bjc.2017.168.

MLA (9th ed.) Citation

Alvi, Muhammad A., et al. "Molecular Profiling of Signet Ring Cell Colorectal Cancer Provides a Strong Rationale for Genomic Targeted and Immune Checkpoint Inhibitor Therapies." British Journal of Cancer, vol. 117, no. 2, 2017, pp. 203-209, https://doi.org/10.1038/bjc.2017.168.